Zymeworks (ZYME) Change in Accured Expenses (2021 - 2026)

Zymeworks has disclosed Change in Accured Expenses across 6 years of filings, most recently posting -$7.8 million for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$7.8 million, up 63.48% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.2 million (down 10.93% YoY), and the FY2025 annual result was -$23.6 million, down 265.13% from the prior year.
• Change in Accured Expenses came in at -$7.8 million for Q1 2026 at Zymeworks, down from $1.3 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $37.6 million in Q4 2022 to a low of -$28.3 million in Q1 2023.
• The 5-year median for Change in Accured Expenses is $1.3 million (2025), against an average of -$2.1 million.
• Across the five-year window, Change in Accured Expenses jumped 551.75% in 2022 and tumbled 1031.47% in 2025, its largest moves.
• Zymeworks' Change in Accured Expenses stood at $37.6 million in 2022, then sank by 159.42% to -$22.3 million in 2023, then jumped by 132.87% to $7.3 million in 2024, then tumbled by 81.8% to $1.3 million in 2025, then slumped by 680.52% to -$7.8 million in 2026.
• The last three Change in Accured Expenses figures came in at -$7.8 million (Q1 2026), $1.3 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.